Search Results - "Dougherty, Tanya"
-
1
Type 2 diabetes in the US managed care setting: the burden of disease and rationale for an oral glucagon-like peptide-1 receptor agonist
Published in The American journal of managed care (01-12-2020)“…Diabetes affects an estimated 34 million US adults, with type 2 diabetes (T2D) accounting for 90% to 95% of cases. The downstream consequences of uncontrolled…”
Get full text
Journal Article -
2
Cardiovascular outcomes, safety, and tolerability with oral semaglutide: insights for managed care
Published in The American journal of managed care (01-12-2020)“…It is important to consider the safety profile of new medications in type 2 diabetes (T2D) when selecting the most appropriate treatment option for each…”
Get full text
Journal Article -
3
The importance of patient-reported outcomes in type 2 diabetes: insight from the PIONEER program with oral semaglutide
Published in The American journal of managed care (01-12-2020)“…Patient-reported outcomes (PROs), including treatment satisfaction, patient well-being, and quality of life, are becoming increasingly important contributors…”
Get full text
Journal Article -
4
Efficacy of oral semaglutide: overview of the PIONEER clinical trial program and implications for managed care
Published in The American journal of managed care (01-12-2020)“…The first tablet formulation of a glucagon-like peptide-1 receptor agonist(GLP-1RA), oral semaglutide, was approved in September 2019 for the treatment of…”
Get full text
Journal Article -
5
The Pharmacists' Role in the Patient-Centered Medical Home (PCMH)
Published in The Annals of pharmacotherapy (01-05-2012)Get full text
Journal Article -
6
-
7